🇺🇸 FDA
Company

VYNE

VYNE Therapeutics

VYNE pharma USA

Quick answer

VYNE is a pharma company (VYNE) headquartered in BRIDGEWATER, NJ, USA with 24 tracked pipeline programs.

Pipeline (24)

project

5 mg Serlopitant Tablets

Pruritus

Phase 3 · small_molecule · terminated

3 trials project

5mg Serlopitant Tablets

Pruritus

Phase 3 · small_molecule · completed

2 trials project

FMX-101, 4% minocycline foam

Acne Vulgaris

Phase 3 · small_molecule · completed

2 trials project

FMX101

Acne Vulgaris

Phase 3 · small_molecule · completed

1 trials project

FMX103 1.5%

Papulopustular Rosacea

Phase 3 · small_molecule · completed

1 trials project

FMX103 minocycline foam 1.5%

Facial Papulopustular Rosacea

Phase 3 · small_molecule · completed

2 trials project

5 mg Serlopitant Tablets

Refractory Chronic Cough

Phase 2 · small_molecule · completed

1 trials project

ARK-E021 5%

Acne Vulgaris

Phase 2 · small_molecule · completed

1 trials project

Comparator: MK0594 5 mg/day

Alcohol Dependence

Phase 2 · small_molecule · terminated

1 trials project

FCD105

Acne Vulgaris

Phase 2 · other · completed

1 trials project

FDX104 (4% Doxycycline)

Rash Due to Epidermal Growth Factor Receptor Inhibitors

Phase 2 · small_molecule · completed

1 trials project

FMX-103 1.5%

Rosacea

Phase 2 · small_molecule · completed

1 trials project

FMX114

Atopic Dermatitis

Phase 2 · small_molecule · completed

1 trials project

MK0594

Urinary Incontinence

Phase 2 · small_molecule · completed

1 trials project

Permethrin Foam 4%

Scabies

Phase 2 · small_molecule · completed

1 trials project

Serlopitant

Pruritus

Phase 2 · small_molecule · terminated

1 trials project

Serlopitant High Dose

Pruritus

Phase 2 · small_molecule · completed

1 trials project

Serlopitant Tablet

Epidermolysis Bullosa

Phase 2 · small_molecule · completed

1 trials project

Topical Minocycline Foam FXFM244

Impetigo

Phase 2 · small_molecule · completed

1 trials project

Topical Minocycline Foam FXFM244

Rosacea

Phase 2 · small_molecule · terminated

1 trials project

Topical Minocycline Foam FXFM244

Acne Vulgaris

Phase 2 · small_molecule · completed

1 trials project

VPD-737

Chronic Pruritus

Phase 2 · small_molecule · completed

1 trials project

VPD-737

Epidermolysis Bullosa

Phase 2 · small_molecule · completed

1 trials project

VYN201 Gel

Non-segmental Vitiligo

Phase 2 · small_molecule · terminated

1 trials

Patents (7)

patent

US 11433025

Oil foamable carriers and formulations

Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11219631

Foamable compositions, breakable foams and their uses

Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11103454

Wax foamable vehicle and pharmaceutical compositions thereof

Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11033491

Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof

Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11026920

Use of NK-1 receptor antagonist serlopitant in pruritus

Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10967063

Surfactant-free, water-free formable composition and breakable foams and their u

Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10946101

Surfactant-free water-free foamable compositions, breakable foams and gels and t

Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)